Eloxx Pharmaceuticals (ELOX) Earnings Analysis
Eloxx Pharmaceuticals (ELOX) next reports earnings on 2026-08-10, consensus EPS -6.4 USD. Trailing P/E -2.14.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ELOX next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -6.4 USD |
| Revenue estimate | n/a |
ELOX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-04-17 | -4.95 USD | n/a | n/a | n/a |
ELOX valuation and analyst view
| Trailing P/E | -2.14 |
|---|---|
| Trailing EPS | -1.24661 USD |
| Price / book | -7.21 |
| Dividend yield | 0.00% |
| Market cap | 0.09B |
| Analyst consensus | Buy (8 buy / 3 hold / 0 sell) |
| Avg price target | 43 USD |
Related research pages
Frequently asked questions
When is Eloxx Pharmaceuticals (ELOX)'s next earnings date?
Eloxx Pharmaceuticals is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -6.4 USD.
Did ELOX beat earnings last quarter?
Consensus estimate data was not available for ELOX's 2025-04-17 report.
What is ELOX's current P/E ratio and EPS?
ELOX trades at a trailing P/E of -2.14 on trailing EPS of -1.2466070860131506 USD.
What do analysts rate ELOX?
Analyst consensus is "Buy" across 11 ratings (0 strong buy, 8 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 43 USD.